SAREPTA THERAP
SAREPTA THERAP operates in Diversified Metals & Mining.
Market Cap & Net Worth: SAREPTA THERAP (AB3A)
SAREPTA THERAP (MU:AB3A) has a market capitalization of $194.67K (€189.65K) as of March 30, 2026. Listed on the MU stock exchange, this Germany-based company holds position #39483 globally and #5569 in its home market, demonstrating a 24.80% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SAREPTA THERAP's stock price €19.02 by its total outstanding shares 9971 (9.97K).
SAREPTA THERAP Market Cap History: 2015 to 2026
SAREPTA THERAP's market capitalization history from 2015 to 2026. Data shows change from $364.06K to $194.67K (-2.34% CAGR).
SAREPTA THERAP Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SAREPTA THERAP's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
SAREPTA THERAP's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $265.96K | $5.42 Million | -$267.26 Million | 0.05x | N/A |
| 2017 | $481.91K | $154.58 Million | -$50.69 Million | 0.00x | N/A |
| 2018 | $960.65K | $301.03 Million | -$361.92 Million | 0.00x | N/A |
| 2019 | $1.18 Million | $380.83 Million | -$715.08 Million | 0.00x | N/A |
| 2020 | $1.43 Million | $540.10 Million | -$554.13 Million | 0.00x | N/A |
| 2021 | $818.18K | $701.89 Million | -$418.78 Million | 0.00x | N/A |
| 2022 | $1.21 Million | $933.01 Million | -$703.49 Million | 0.00x | N/A |
| 2023 | $900.27K | $1.24 Billion | -$535.98 Million | 0.00x | N/A |
Competitor Companies of AB3A by Market Capitalization
Companies near SAREPTA THERAP in the global market cap rankings as of March 30, 2026.
Key companies related to SAREPTA THERAP by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2403 globally with a market cap of $6.01 Billion USD ( €5.86 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2442 globally with a market cap of $5.88 Billion USD ( €5.73 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3696 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4600 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2403 | BERKSHIRE HATH-A | BE:BRH | $6.01 Billion | €634500.00 |
| #2442 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $5.88 Billion | €610500.00 |
| #3696 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4600 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
SAREPTA THERAP Historical Marketcap From 2015 to 2026
Between 2015 and today, SAREPTA THERAP's market cap moved from $364.06K to $ 194.67K, with a yearly change of -2.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €194.67K | +2.40% |
| 2025 | €190.11K | -83.81% |
| 2024 | €1.17 Million | +30.46% |
| 2023 | €900.27K | -25.62% |
| 2022 | €1.21 Million | +47.94% |
| 2021 | €818.18K | -42.70% |
| 2020 | €1.43 Million | +20.95% |
| 2019 | €1.18 Million | +22.89% |
| 2018 | €960.65K | +99.34% |
| 2017 | €481.91K | +81.20% |
| 2016 | €265.96K | -26.95% |
| 2015 | €364.06K | -- |
End of Day Market Cap According to Different Sources
On Mar 29th, 2026 the market cap of SAREPTA THERAP was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $194.67K USD |
| MoneyControl | $194.67K USD |
| MarketWatch | $194.67K USD |
| marketcap.company | $194.67K USD |
| Reuters | $194.67K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.